Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
Not Applicable
Completed
- Conditions
- Dry Eye SymptomsVisual Performance
- Registration Number
- NCT00938951
- Lead Sponsor
- Alcon Research
- Brief Summary
The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
- Player/ Coach must answer "Yes" to the survey eligibility question.
- Player/Coach must voluntarily agree to participate in survey
Exclusion Criteria
- None.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Effectiveness of eye drop basd on athlete's opinion/experience during a one hour practice session 60 minutes post-dosing with test article
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does Systane Ultra utilize to alleviate dry eye symptoms and improve visual performance?
How does Systane Ultra compare to standard-of-care artificial tears in managing ocular irritation during physical stress?
Are there specific biomarkers associated with improved visual degradation outcomes after Systane Ultra administration?
What adverse events are commonly reported with Systane Ultra in clinical trials and how are they managed?
What are the potential combination therapies involving Systane Ultra for enhanced dry eye symptom relief?